Erythropoietin treatment for ischemic cardiomyopathy: anemia correction and myocardial protection.
Ben-Dor
Itsik
I
Cardiology Department, Rabin Medical Center and Felsenstein Medical Research Center, Petach Tikva, Israel.
Battler
Alexander
A
D000740:Anemia / Q000175:diagnosis / Q000188:drug therapy*; D000818:Animals; D004195:Disease Models, Animal; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000517:prevention & control*; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D011994:Recombinant Proteins; D018570:Risk Assessment; D013318:Stroke Volume / Q000187:drug effects; D016019:Survival Analysis; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin